Drug intelligence / Profile preview

DRT102-sp

Development stage
Preclinical
Lead developer
Darnatein
Modality
Recombinant Proteins and Enzymes
Administration
Implant
01

Overview

DRT102-sp is an engineered bone morphogenetic protein (BMP) biobetter in the design and concept stages of development by OSR Holdings and its subsidiary, Darnatein. Utilizing the proprietary DA-BMP (Darnatein-BMP) platform, the asset is designed to enhance BMP pathway activity to support bone and spinal regeneration. The program is currently being explored for orthopedic and dental applications, including lumbar stenosis, disc herniation, spinal fusion, dental augmentation, and non-union bone fractures. It represents an earlier-stage iteration or specialized version of the core DRT-102 program, focusing on targeted bone growth and structural repair.

Other names
DRT102-spDRT-102-spDRT 102-spDA-BMP
02

Targets

BMPR2 (Bone morphogenetic protein receptor type II)ACVR1 (Activin receptor type I)BMP1 (Bone morphogenetic protein 1)ACVR2A (Activin receptor type 2A)

Beyond the preview

Go deeper on DRT102-sp.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DRT102-sp.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call